GUIDANCE HIPAA

Download

This document provides guidance about the research use of protected health information (PHI), as governed by federal HIPAA regulations, WA state laws, and ÌìÃÀÓ°Ôºinstitutional policies.

Change Notes

Updates for accessibility – 02.26.2026
Revised to reference ÌìÃÀÓ°ÔºMedicine’s new honest broker policy and policy for the release of clinical data. – 08.29.2025
Update information about allowable eSignatures for HIPAA; Update subject to participant where applicable – 06.26.2025
Add note that HIPAA Authorization for ÌìÃÀÓ°ÔºMedicine PHI may not be obtained using language in the research consent form – 05.01.2025
Add information about PHI at non-ÌìÃÀÓ°Ôºcovered entities. Remove reference to ÌìÃÀÓ°Ôºas IRB of Record for Bloodworks, Northwest Kidney Centers, and PHSKC – 04.27.2023
Removed reference to SCCA – 09.20.2022
Additional clarification about decedents and HIPAA – 11.23.2021
Updated information about decedents and Washington State law RCW 70.02; updated links – 06.24.2021